Intermediate term biochemical progression rates after radical prostatectomy and radiotherapy in patients with screen detected prostate cancer

Journal of Urology

Volumn 174, Issue 1, 2005, Pages 126-130

  Krygiel, Julie M ^a   Smith, Deborah S ^e   Homan, Sharon M ^b   Sumner II, Walton ^c   Nease Jr , Robert F ^d   Brownson, Ross C ^b   Catalona, William J ^f  

^a Waterman Research Solutions   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Express Scripts   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Disease progression; Prostate specific antigen; Prostatectomy; Prostatic neoplasms; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SCREENING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 20444473096     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000162051.15616.70     Document Type: Article

References (18)

1. Smith, D. S., Humphrey, P. A. and Catalona, W. J.: The early detection of prostate carcinoma with prostate specific antigen: the Washington University experience. Cancer, 80: 1852, 1997
2. Catalona, W. J., Smith, D. S., Ratliff, T. L. and Basler, J. W.: Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA, 270: 948, 1993
3. Smith, D. S., Catalona, W. J. and Herschman, J. D.: Longitudinal screening for prostate cancer with prostate-specific antigen. JAMA, 276: 1309, 1996
4. Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D. E., Yuan, J. J. et al: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med, 324: 1156, 1991
5. Smith, D. S., Carvalhal, G. F., Schneider, K., Krygiel, J., Yan, Y. and Catalona, W. J.: Quality-of-life outcomes for men with prostate carcinoma detected by screening. Cancer, 88: 1454, 2000
6. Montie, J. E.: Staging of prostate cancer. Cancer, 74: 1, 1994
7. Fleming, I. D., Cooper, J. S., Hensen, D. E., Hutter, R. V., Kennedy, B. J., Murphy, S. P. et al: AJCC Cancer Staging Manual, 5th ed. Philadelphia: Lippincott-Raven, 1997
8. Gleason, D. F., Mellinger, G. T. and the Veterans Administration Cooperative Urological Research Group: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol, 111: 58, 1974
9. Consensus statement: Guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys, 37: 1035, 1997
10. Rosenbaum, P. R. and Rubin, D. B.: Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc, 79: 516, 1984
11. Cox, D. R.: Regression models and life-tables. J R Stat Soc Ser B, 34: 187, 1972
12. Kaplan, E. L. and Meier, P.: Nonparametric estimation from incomplete observations. J Am Stat Assoc, 53: 457, 1958
13. Gretzer, M. B., Trock, B. J., Han, M. and Walsh, P. C.: A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for Therapeutic Radiation and Oncology criteria. J Urol, 168: 1419, 2002
14. Han, M., Partin, A. W., Zahurak, M., Piantadosi, S., Epstein, J. I. and Walsh, P. C.: Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol, 169: 517, 2003
15. D'Amico, A. V., Schultz, D., Loffredo, M., Dugal, R., Hurwitz, M., Kaplan, I. et al: Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer. JAMA, 284: 1280, 2000
16. Kestin, L. L., Vicini, F. A., Ziaja, E. L., Stromberg, J. S., Frazier, R. C. and Martinez, A. A.: Defining biochemical cure for prostate carcinoma patients treated with external beam radiation therapy. Cancer, 86: 1557, 1999
17. Pound, C. R., Partin, A. W., Eisenberger, M. A., Chan, D. W., Pearson, J. D. and Walsh, P. C.: Natural history of progression after PSA elevation following radical prostatectomy. JAMA, 281: 1591, 1999
18. Amling, C. L., Bergstralh, E. J., Blute, M. L., Slezak, J. M. and Zincke, H.: Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point? J Urol, 165: 1146, 2001